Technical Articles
muscle atrophy
ActRIIB Protein: The "Core Brake" of Muscle Growth and a Revolutionary Target for Next-Generation Therapeutics
The activin receptor type IIB (ActRIIB) is a pivotal signaling hub in the transforming growth factor-β (TGF-β) superfamily. Far from being a simple receptor, it serves as a "master switch" regulating muscle growth, erythropoiesis, and systemic metabolic homeostasis.
View details
- Signaling Pathway
- ActRIIB
- TGF-β
- Activin Receptor Type-2B
- Muscle Atrophy
- Cancer Cachexia
ActRIIB Protein: The "Core Brake" of Muscle Growth and a Novel Therapeutic Target for Diseases
ActRIIB (Activin Receptor Type IIB) is a key signaling receptor in the TGF-β superfamily, serving as the "core negative regulator" of muscle growth and playing a decisive role in muscle atrophy diseases, anemia, and metabolic disorders.
View details
- Cancer
- ActRIIB
- TGF-β
- Activin Receptor Type-2B
- Muscle Atrophy
- Cancer Cachexia
Activin A Protein: From Key Physiological Regulator to Novel Therapeutic Target
Activin A, a key member of the TGF-β superfamily, is a dimeric protein formed by two βA subunits linked via disulfide bonds. This critical signaling molecule plays a central role in physiological processes such as embryonic development, tissue repair, and immune regulation, but its dysregulation has also become a pivotal factor in the pathogenesis of various diseases.
View details
- Cancer
- Activin A protein
- TGF-β superfamily
- fibrotic diseases
- tumor progression
- muscle atrophy
Activin A: A Double-Edged Sword in Regulating Life Processes
Activin A is a secreted protein belonging to the transforming growth factor-β superfamily. Like other well-known family members such as TGF-β and BMPs, it plays a central role in cell growth, differentiation, and apoptosis.
View details
- Cancer
- Activin A protein
- TGF-β superfamily
- fibrotic diseases
- tumor progression
- muscle atrophy
- 1















